New hope for easing chemo sickness in breast cancer patients
NCT ID NCT07254416
Summary
This study aims to find the best way to prevent nausea and vomiting in breast cancer patients receiving a specific chemotherapy drug called T-DXd. It will compare two different combinations of anti-nausea medications over two treatment cycles. The goal is to help patients complete their cancer treatment with fewer side effects and better quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER PATIENTS TREATED WITH T-DXD are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.